COMPARISON BETWEEN HALOPERIDOL AND RISPERIDONE IN DEVELOPMENT OF METABOLIC SYNDROME IN INDIAN PATIENTS

Journal Title: European Journal of Biomedical and Pharmaceutical Sciences - Year 2019, Vol 6, Issue 6

Abstract

Introduction: It is well known that anti-psychotics are associated with many side effects. One of the significant adverse drug reactions among these is weight gain and development of metabolic syndrome. In this study, we compared the most widely used drugs Haloperidol and Risperidone for development of metabolic syndrome in treatment naïve patients with one episode of Schizophrenia. Methods: We took a total of 45 patients who were diagnosed to have Schizophrenia. All these patients never took any anti-psychotic in their live, nor did they take any other medicine for CNS/Psychiatry disorder. Among these 45 patients, 16 patients were put on Haloperidol and 29 patients were prescribed Risperidone. Patients with endocrine disturbances, any systemic disorders, etc. were removed from the study. The baseline characteristics of all the patients were properly studied and recorded. The characteristics were recorded again after 6 months and comparison was done by statistical methods. Results: PANSS score showed a decrease in both groups, systolic blood pressure showed an increase with Haloperidol and an initial decrease with risperidone while diastolic blood pressure increased with haloperidol. Weight gain, increase in waist circumference, rise in triglyceride levels and fall in HDL cholesterol were equally observed in both groups. Increase in plasma glucose was seen more with risperidone (93.1%). 18.86% (n = 10) developed metabolic syndrome at the end of 6months with no difference in emergence between both groups. Conclusion: Risperidone is considered equivalent to Haloperidol in efficacy but it is associated with increase in the components of metabolic syndrome.

Authors and Affiliations

Chaitanya Patel

Keywords

Related Articles

EVALUATION OF SOCIAL MEDIA AS A SOURCE OF HEALTH INFORMATION AMONG MALE STUDENTS AT TAIF UNIVERSITY

Background: To improve young people's access to health information sources, new strategies that are attractive to them are beginning to emerge, and they make use of the power, creativity, and enthusiasm of this populatio...

HALPHABAROL THERAPY IN EGYPTIAN PATIENTS WITH CIRRHOSIS AND DIURETIC-RESISTANT ASCITES

Background: Liver cirrhosis accounts for over 75% of all episodes of ascites. One of the most serious complications in cirrhotic patients with ascites is the occurrence of refractoriness that is the inability to resolve...

ASSOCIATION BETWEEN POLY CYSTIC OVARIES SYNDROME AND SERUM LEVEL OF CHROMIUM, ZINC AND MAGNESIUM

Background Polycystic ovary syndrome (PCOS), as the most prevalent endocrine disorder in reproductive-aged women, is associated with reproductive and metabolic abnormalities. Despite the large literature on the role of d...

NEEDLE FREE INJECTION TECHNOLOGY

The Needle-free injection (NFI) systems are novel ways to introduce various medicines Needle free injection technology was developed to reduce the number of needle stick accidents and associated problems. It is an extrem...

MOLECULAR TYPING OF PROBIOTIC BACTERIA: A REVIEW

Identification of probiotics bacteria with phenotypic technique is difficult, not reliable and efficient to classify them up to species level. Since probiotics effects are known to be strain specific, proper identificati...

Download PDF file
  • EP ID EP670953
  • DOI -
  • Views 150
  • Downloads 0

How To Cite

Chaitanya Patel (2019). COMPARISON BETWEEN HALOPERIDOL AND RISPERIDONE IN DEVELOPMENT OF METABOLIC SYNDROME IN INDIAN PATIENTS. European Journal of Biomedical and Pharmaceutical Sciences, 6(6), 121-123. https://europub.co.uk/articles/-A-670953